Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    1101 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 33
    1102 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 31
    1103 Apheresis Allogeneic B-Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 62
    1104 Apheresis Allogeneic B-Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 62
    1105 Apheresis Allogeneic Hemophagocytic lymphohistiocytosis Hematology 2025 Standard Therapy Czechia 27
    1106 Apheresis Allogeneic Shwachman-Diamond Syndrome Hematology 2025 Standard Therapy Spain 11
    1107 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 67
    1108 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 60
    1109 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy CROATIA 43
    1110 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 69
    1111 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Austria 61
    1112 Apheresis Allogeneic Other Immune System Hematology 2025 Standard Therapy USA 62
    1113 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 74
    1114 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 63
    1115 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 66
    1116 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 50
    1117 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62
    1118 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Australia 71
    1119 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 76
    1120 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Canada 66
    1121 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 74
    1122 Apheresis Allogeneic Morbus Hodgkin Hematology 2025 Standard Therapy Germany 21
    1123 Apheresis Allogeneic Myelodysplastic Disorders Hematology 2025 Standard Therapy France 66
    1124 Apheresis Allogeneic Mielodysplastic Syndrome Hematology 2025 Standard Therapy USA 65
    1125 Apheresis Allogeneic T Lymphoblastic Lymphoma Hematology 2025 Standard Therapy Portugal 25
    1126 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Romania 29
    1127 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 37
    1128 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 49
    1129 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 32
    1130 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 72
    1131 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 43
    1132 Apheresis Allogeneic Hodking lymphoma Hematology 2025 Standard Therapy Serbia 32
    1133 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 66
    1134 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 71
    1135 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 66
    1136 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 68
    1137 Apheresis Allogeneic OMDS/ Myeloproliferative Neoplasie Hematology 2025 Standard Therapy Switzerland 46
    1138 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 3
    1139 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 75
    1140 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 58
    1141 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Greece 63
    1142 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 64
    1143 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 65
    1144 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Spain 49
    1145 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 30
    1146 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 66
    1147 Apheresis Allogeneic Chronic Lymphocyte Leukemia Hematology 2025 Standard Therapy Canada 55
    1148 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy USA 64
    1149 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 16
    1150 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 73
    1151 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Ukraine 47
    1152 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 64
    1153 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 67
    1154 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 65
    1155 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 58
    1156 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Germany 57
    1157 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy RUSSIAN FEDERATION 22
    1158 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 33
    1159 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Slovakia 41
    1160 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Greece 54
    1161 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Ukraine 46
    1162 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Argentina 26
    1163 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 70
    1164 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 59
    1165 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 34
    1166 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Norway 53
    1167 Apheresis Allogeneic Other Immune System Hematology 2025 Standard Therapy USA 19
    1168 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 6
    1169 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 68
    1170 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 72
    1171 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 64
    1172 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy United Kingdom 33
    1173 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Italy 63
    1174 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 33
    1175 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 61
    1176 Apheresis Allogeneic Acute lymphocytic leukemia Hematology 2025 Standard Therapy Germany 51
    1177 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 64
    1178 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 54
    1179 Apheresis Autologous Testicular tumor Hematology 2025 Standard Therapy Germany 42
    1180 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 52
    1181 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 49
    1182 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 73
    1183 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 62
    1184 Apheresis Autologous Lymphoma Hodgkin Hematology 2025 Standard Therapy Portugal 39
    1185 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 60
    1186 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 70
    1187 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 64
    1188 Apheresis Autologous T-Cell Lymphoma Hematology 2025 Standard Therapy Germany 60
    1189 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 62
    1190 Apheresis Autologous Mantle Cell Lymphoma Hematology 2025 Standard Therapy Germany 60
    1191 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 43
    1192 Apheresis Allogeneic Myeofibrosis Hematology 2025 Standard Therapy Poland 37
    1193 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 22
    1194 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy NETHERLANDS 66
    1195 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 57
    1196 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 56
    1197 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 78
    1198 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 65
    1199 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 53
    1200 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Portugal 41